Evidence map›Paper›PMID 42449696›Full record

ArticleCancers2026

Multimodal Fusion of Intraoperative FLIm and Preoperative PET/CT for Patient-Level Prediction of Lymph Node Metastasis in Head and Neck Cancer.

Lei Zhou, Nimu Yuan, Mohamed A Hassan, Lisanne Kraft, Katjana Ehrlich, Brent W Weyers, Vladimir Ivanovic, Osama A A Raslan, Dorina Gui, Marianne Abouyared and 5 more

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lei ZhouDepartment of Biomedical Engineering, University of California, Davis, CA 95616, USA.ORCID 0009-0007-9394-309X
Nimu YuanDepartment of Biomedical Engineering, University of California, Davis, CA 95616, USA.ORCID 0009-0003-8434-2015
Mohamed A HassanDepartment of Biomedical Engineering, University of California, Davis, CA 95616, USA.ORCID 0000-0002-3076-8075
Lisanne KraftDepartment of Biomedical Engineering, University of California, Davis, CA 95616, USA.
Katjana EhrlichDepartment of Biomedical Engineering, University of California, Davis, CA 95616, USA.ORCID 0000-0002-8387-9641
Brent W WeyersDepartment of Biomedical Engineering, University of California, Davis, CA 95616, USA.ORCID 0000-0002-1939-3401
Vladimir IvanovicDepartment of Neurology, University of California, Davis, CA 95817, USA.
Osama A A RaslanDepartment of Radiology, University of California, Davis, CA 95817, USA.
Dorina GuiDepartment of Pathology and Laboratory Medicine, University of California, Davis, CA 95817, USA.ORCID 0000-0002-1500-6689
Marianne AbouyaredDepartment of Otolaryngology-Head and Neck Surgery, University of California, Davis, CA 95817, USA.ORCID 0000-0002-2779-5494
Arnaud F BewleyDepartment of Otolaryngology-Head and Neck Surgery, University of California, Davis, CA 95817, USA.ORCID 0000-0002-1524-1806
Andrew C BirkelandDepartment of Otolaryngology-Head and Neck Surgery, University of California, Davis, CA 95817, USA.ORCID 0000-0003-2500-2857
Donald Gregory FarwellDepartment of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0003-3421-4202
Laura MarcuDepartment of Biomedical Engineering, University of California, Davis, CA 95616, USA.ORCID 0000-0003-2369-0748
Jinyi QiDepartment of Biomedical Engineering, University of California, Davis, CA 95616, USA.ORCID 0000-0002-5428-0322

Funding

TRD3: Data Analytics and Intelligent Systems (AI-ML-DL-Visualization)P41EB032840 · NIBIB · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Griffith R. Harsh, Laura Marcu · 2022 to 2026
$6.7M
Fluorescence Lifetime Imaging/Spectroscopy System For Robotic Cancer Surgery GuidanceR01CA187427 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BIRKELAND, ANDREW CHARLES, MARCU, LAURA · 2014 to 2025
$4.6M
NCI NIH HHS R01 CA187427NIBIB NIH HHS P41 EB032840NIH HHS P41 EB032840 and R01 CA187427
6 · The paper itself

Abstract

backgroundMetastatic lymph node (MLN) detection remains a major clinical challenge in head and neck cancer, as nodal involvement is strongly associated with poor prognosis and directly affects treatment planning. Previous approaches typically rely on cropped lymph node (LN) regions or tumor contours for MLN identification, requiring substantial expert annotation during preprocessing and relying solely on imaging information. As a result, small or low-contrast metastatic nodes may be missed, while benign lymph nodes may be incorrectly identified as metastatic due to overlapping imaging characteristics. To address these limitations, we propose a multimodal learning framework that integrates anatomical and metabolic features from head and neck PET/CT images with biochemical features derived from FLIm for patient-level MLN prediction, without requiring manual lymph node cropping or tumor contouring during inference.

methodsTo enable robust imaging representation learning, a region-aware PET/CT network based on a merging-diverging architecture was first pretrained on the HECKTOR 2022 dataset and then fine-tuned on the institutional cohort. In parallel, FLIm point-wise measurements with clinical variables were encoded using a multilayer perceptron (MLP) and aggregated into subject-level representations. To effectively combine these modalities, two multimodal fusion strategies were evaluated at the decoder stage, including cube-based fusion and squeeze-and-excitation (SE)-based fusion. The proposed strategies were evaluated on a cohort of 53 patients.

resultsCompared with the single-modality baselines, both multimodal fusion strategies achieved better patient-level MLN prediction. The PET/CT-only segmentation-driven model and FLIm-only model reached balanced accuracies of 0.815 and 0.665, with AUCs of 0.828 and 0.614, respectively. Cube-based fusion improved balanced accuracy and AUC to 0.827 and 0.850, respectively, while channel-wise SE-based fusion achieved the best overall performance, with a balanced accuracy of 0.839 and an AUC of 0.872.

conclusionsThese results suggest that multimodal integration may improve patient-level MLN prediction compared with single-modality approaches. Given the limited sample size, these findings should be interpreted as hypothesis-generating and require validation in larger, independent patient cohorts.

Indexed as

deep learningfluorescence lifetime imaginghead and neck cancermetastatic lymph nodemultimodal fusionpatient-level predictionPET/CT

Identifiers

PMID42449696
PMCPMC13359770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.